cbdMD, Inc. (NYSE: YCBD) reported Q4 EPS of ($0.08), $0.27 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $11.5 million.

For earnings history and earnings-related data on cbdMD, Inc. (YCBD) click here.